ReviewTumour Biol2013
Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.
- Journal
- Tumour Biol
- Published
- 17 August 2013
- Citations
- 87
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic adenocarcinoma accounts for nearly 90-95% of exocrine malignant tumors of the pancreas. Traditionally, overexpressed proteins/epitopes such as CA 19-9, CA-50, CEA, and many others were being used as pancreatic cancer tumor markers. … Excerpt only: this text is the publisher’s. Read it in full at the source.